These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26870006)

  • 1. Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.
    Wang J; Hao H; Huang L; Liu Z; Chen D; Yuan Z
    Front Microbiol; 2016; 7():36. PubMed ID: 26870006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
    Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
    J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
    Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
    Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
    Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S
    J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
    Balaje RM; Sidhu PK; Kaur G; Rampal S
    Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
    Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
    BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK/PD modelling of enrofloxacin against Glaesserella parasuis infection in pigs.
    Yang B; Li XD; Chen X; Hong J; Liu C; Zheng JP; Ou ZY; Yu DJ
    J Vet Pharmacol Ther; 2022 May; 45(3):291-300. PubMed ID: 35348230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PK-PD integration and modeling of marbofloxacin in sheep.
    Sidhu PK; Landoni MF; Aliabadi FS; Lees P
    Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
    Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
    Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
    J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of G.I.T. disease in pigs.
    Guyonnet J; Manco B; Baduel L; Kaltsatos V; Aliabadi MH; Lees P
    Res Vet Sci; 2010 Apr; 88(2):307-14. PubMed ID: 19945722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant cutoff values and optimal scheme establishments for florfenicol against Escherichia coli with PK-PD modeling analysis in pigs.
    Lei Z; Liu Q; Khaliq H; Cao J; He Q
    J Vet Pharmacol Ther; 2019 May; 42(3):324-335. PubMed ID: 30801741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
    Gebru E; Choi MJ; Lee SJ; Damte D; Park SC
    J Med Microbiol; 2011 Oct; 60(Pt 10):1512-1522. PubMed ID: 21596912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
    Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
    BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of enrofloxacin in southern crested caracaras (Caracara plancus).
    Waxman S; Prados AP; de Lucas J; San Andres MI; Sassaroli JC; Orozco M; Argibay H; Rodriguez C
    J Avian Med Surg; 2013 Sep; 27(3):180-6. PubMed ID: 24344508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
    Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
    BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.